Oxis Intl., Inc.

Oxis Intl., Inc. — FDA 510(k) Submissions

Oxis Intl., Inc. has submitted 11 FDA 510(k) premarket notifications since 1995, of which 11 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Fluorescence Polarization Immunoassay, Phenobarbital, Discs, Strips And Reagents, Microorganism Differentiation, Fluorescence Polarization Immunoassay, Diphenylhydantoin (total), Fluorescence Polarization Immunoassay, Theophylline, Enzyme Immunoassay, Quinidine . Use the specialty filter in the sidebar to narrow results.